U.S. Patent Office Reinstates Longhorn Vaccines’ Patents, Prompting Withdrawal of Company Appeal

The U.S. Patent and Trademark Office’s recent decision to reverse the cancellation of five Longhorn Vaccines & Diagnostics LLC patents has led the company to withdraw its appeal in the case. This development follows the intervention of the acting director, who overturned a previous ruling that had nullified the patent claims due to alleged misconduct. The impact of this decision could bear significance on corporate patent strategies and procedures moving forward Read more about this case on Law360.